---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-030853"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2025-08-13T23:59:59+00:00"
generated_at: "2026-05-17T13:50:40.050031+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Strata Skin Sciences Q2 revenue down 9% to $7.7M; net loss widens to $2.5M, EPS -$0.60

## Summary
- Revenue $7.7M (down 9% YoY); net loss $2.5M vs $0.1M loss in Q2 2024 (EPS -$0.60 vs -$0.03).
- Gross profit $4.3M (56% of revenue) vs $5.0M in prior year.
- Cash at June 30 $6.0M; nearly operating cash flow breakeven when adjusted for $1.3M NY tax payment and ~$340k legal costs.
- CPT code expansion triples covered patient population; G-code application filed for accelerated 2026 reimbursement.
- Removed 21 XTRAC devices, placed 19 (highest in six quarters); lawsuit against LaserOptek adds defendants.

## SEC filing metadata
- accession: 0001140361-25-030853
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2025-08-13T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000114036125030853/0001140361-25-030853-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000114036125030853/ef20053890_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-030853
- JSON: https://secwatch.observer/filing/0001140361-25-030853.json
- Plain text: https://secwatch.observer/filing/0001140361-25-030853.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.